nbfc

7th Aug’20 – Jun’20 earnings update on Manappuram and Aarti Drugs

Dear Members, We have released 7th Aug’20 – Jun’20 earnings update on Manappuram Finance and Aarti Drugs. The same has been produced below. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 7th Aug’20   Manappuram Finance (NSE – MANAPPURAM) – Jul’17 Alpha stock CMP – 161.60 (BSE); 161.60 (NSE) Rating – Positive – 8% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Manappuram has reported decent set of numbers for Q1 FY 21; however,…

Read More

Manappuram Finance – Stock idea at 20-20 TIA 2018

Dear Sir, We presented a stock idea at the recently concluded 20-20 Ideas summit of TIA. Our presentation was on Manappuram Finance Ltd (NSE Code – MANAPPURAM). The same can be accessed below.   Manappuram Finance: Ekansh Mittal – TIA Presentation 2018 from Katalyst Wealth   Disclosure: I have personal investment in Manappuram Finance and the stock has been recommended to clients as well.   Best Regards, Ekansh Mittal Research Analyst https://www.katalystwealth.com/ Ph.: +91-727-5050062, Mob: +91-9818866676 Email: [email protected]   Research Analyst Details Name: Ekansh Mittal   …

Read More
Copy Protected by Chetan's WP-Copyprotect.